This funding round was co-led by SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis. Additional support came from existing investor Morningside, alongside new investors Tenmile, Brandon Capital, and others.
Sanofi Ventures joins investors backing Australian radionuclide company
February 6, 2025 Australian Biotech
Latest Video
New Stories
-
BPDInsights one week out with patient voices leading the agenda
May 11, 2026 - - Latest News -
It's mostly a mistake to read too much into a Budget forecast because of what it doesn't include
May 11, 2026 - - Latest News -
Budget silence on HTA Review would confirm what we already know - delayed rollout
May 9, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 8 May 2026
May 8, 2026 - - Podcast -
Lilly marks 150 years by lighting a new horizon for health at Vivid Sydney
May 8, 2026 - - Latest News -
The approaching major change in Australia’s PBS wholesaling arrangements
May 8, 2026 - - Latest News -
Victoria joins state-funded MenB programs as PBAC rejection creates another 'postcode lottery'
May 8, 2026 - - Latest News
